FIELD: biotechnology.
SUBSTANCE: group of inventions including a lipid nanoparticle for the treatment of liver tumor diseases in a patient, a pharmaceutical composition for the treatment of a liver tumor disease in a patient, and the use of a pharmaceutical composition for the production of a drug for the treatment of a liver tumor disease in a patient are described.
EFFECT: invention expands the arsenal of agents for the treatment of tumor diseases of the liver in a patient.
7 cl, 3 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
| METHOD FOR FORMING IMMUNE SURVEILLANCE SYSTEM FOR TUMOUR CELLS IN MAMMAL BODY | 2024 |
|
RU2828654C1 |
| NUCLEIC ACID CONTAINING REGULATORY ELEMENTS H4C2, AES AND MTRNR1 | 2023 |
|
RU2831168C1 |
| NUCLEIC ACID CONTAINING REGULATORY ELEMENTS TPL, AES AND mtRNR1 | 2023 |
|
RU2831163C1 |
| NUCLEIC ACID CONTAINING REGULATORY ELEMENTS OF RABBIT β-GLOBIN GENE, mtRNR1 AND AES | 2023 |
|
RU2831164C1 |
| NUCLEIC ACID CONTAINING REGULATORY ELEMENTS OF RABBIT β-GLOBIN GENE, mtRNR1 AND EMCV | 2023 |
|
RU2831165C1 |
| BISPECIFIC ANTIBODIES AND THEIR APPLICATIONS | 2022 |
|
RU2821577C2 |
| BCMA-SPECIFIC CHIMERIC ANTIGEN RECEPTORS CONTAINING IL-6 SIGNALLING BLOCKER | 2023 |
|
RU2828294C1 |
| METHOD FOR REDUCING RESISTANCE OF GLIOBLASTOMA CELLS TO TEMOZOLOMIDE | 2023 |
|
RU2829888C1 |
| MONOCLONAL ANTIBODIES AGAINST THE RECEPTOR-BINDING DOMAIN OF SARS-COV-2 SPIKE PROTEIN AND THEIR ANTIGEN-BINDING FRAGMENTS ENCODING THEIR NUCLEIC ACIDS, AS WELL AS METHODS OF THEIR USE | 2021 |
|
RU2800649C2 |
